Skip to main content
Signal8

SHAH BIMAL R.

SEC insider (Form 3/4/5 filer). CIK 0001557394. Director at Anebulo Pharmaceuticals, Inc. (ANEB). 2 reported Form 4/5 transactions since Sep 2024; latest on Apr 4, 2025. Located in LAKEWAY,, TX.

Companies SHAH BIMAL R. has filed insider reports for

  • Anebulo Pharmaceuticals, Inc. (ANEB): Director
SHAH BIMAL R. profile photo

SHAH BIMAL R.

CIK: 0001557394

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Anebulo Pharmaceuticals, Inc. logo
ANEB

Anebulo Pharmaceuticals, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Anebulo Pharmaceuticals, Inc. logo
    ANEB

    Anebulo Pharmaceuticals, Inc.

    Apr 4, 2025
    Award

    Stock Option (right to buy)

    Direct
    25K shares-
  • Anebulo Pharmaceuticals, Inc. logo
    ANEB

    Anebulo Pharmaceuticals, Inc.

    Apr 4, 2025
    Award

    Stock Option (right to buy)

    Direct
    6.6K shares-

1-2 of 2